Blood test guides Life-Saving treatment to stop Cancer's return

NCT ID NCT06914011

Summary

This study aims to see if a personalized treatment plan can prevent esophageal cancer from coming back after surgery. It will enroll 172 patients who have had their cancer surgically removed but still have tiny amounts of cancer DNA in their blood, putting them at high risk for recurrence. These patients will be randomly assigned to either receive a combination of chemotherapy and immunotherapy drugs or to be closely monitored without additional drug treatment, to see which approach better keeps the cancer away.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.